Announcements Trials
Browse Landscape

Phase

Phase EARLY_PHASE1 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Plasma cell 1Other hematologic neoplasm 1Myeloid 1

Conditions

Myelodysplastic Syndromes 1Multiple Myeloma 1Leukemia, Myeloid, Acute 1Leukemia, Myelogenous, Chronic, BCR-ABL Positive 1Hematopoietic and Lymphoid System Neoplasm 1

Interventions

Azacitidine 2pembrolizumab 1ioversol 1interferon gamma-1b 1fludarabine phosphate 1fluarix 1daratumumab 1Whole-Body Irradiation 1Transplantation 1Stem Cell Transplantation 1Photopheresis 1Pemetrexed 1N-(cyanomethyl)-4-(2-((4-(4-morpholinyl)phenyl)amino)-4-pyrimidinyl)benzamide 1Mycophenolic Acid 1Mesenchymal Stem Cell Transplantation 1Injections 1Influenza Vaccines 1Hyperbaric Oxygenation 1Fluzone High-Dose 1FluLaval 1FluBlok 1Decitabine 1Cyclosporine 1Cyclophosphamide 1Cord Blood Stem Cell Transplantation 1Contrast Media 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase EARLY_PHASE1 × Myelodysplastic Syndromes × Contrast Media × Clear all
NCT02117115 2015-06-11

GVHD

Washington University School of Medicine

Phase EARLY_PHASE1 Completed
21 enrolled
MyeloidOther hematologic neoplasmPlasma cell

Multiple Myeloma, Myelodysplastic Syndromes, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Leukemia, Myeloid, Acute

Data powered by HemOnc (CC BY 4.0) Colophon âš¡